Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Marc Duey

Director at Aprea Therapeutics, Inc. (APRE)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-16.7%
vs. S&P 500-15.1%
Beat the market0%
Paper profit on buys−$12K
Total bought / sold$25K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Dec 11SEC APREAprea Therapeutics, Inc. Buy 21,459256,155 held (+9%) $1.17 $25K -48.4%
  • Buy

    Director Marc Duey bought $25K of APRE at $1.17 — first open-market purchase in our records.